doi: 10.1016/j.mito.2017.11.002 20 MonteithAJMillerJMWilliamsJMVossKRathmellJCCroffordLJet al
Lancet Child Adolesc Health 3(9):595597 Hansen HH, Barkholt P, Fabricius K, Jelsing J, Terwel D, Pyke C, Knudsen LB, Vrang N (2016) The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
943 The results showed that NG/EDA could penetrate the BBB and accumulate efficiently at the site of cerebral ischemic injury in rats with pMCAO
Evidence of metastasis or likelihood of metastasis is expected
It is not approved for human or veterinary use , and may not be used in food, drugs, diagnostic procedures, or cosmetics
February 8, 2024Ritesh Kumar Dr